Somatostatin bolus injection for post-ERCP pancreatitis prevention: a need for further study.
D002760:Cholangiopancreatography, Endoscopic Retrograde / Q000009:adverse effects*; D016670:Gabexate / Q000627:therapeutic use; D006801:Humans; D007267:Injections; D010195:Pancreatitis / Q000209:etiology / Q000517:prevention & control*; D015842:Serine Proteinase Inhibitors / Q000008:administration & dosage*; D013004:Somatostatin / Q000008:administration & dosage* / Q000627:therapeutic use*
D015842:Serine Proteinase Inhibitors; D016670:Gabexate; D013004:Somatostatin